Our mission is to prevent and treat severe GI diseases by restoring and protecting the GI mucosal-immune system and advancing our therapeutic pipeline and GI discovery platform.
First in class evidence-based solutions to treat and prevent human disease by diagnosing and treating dysbiosis.
Generating data to develop microbiome-based interventions.